• Home
  • Blog
  • Newsroom
  • Publications
  • Jobs
  • Contact us
Search main website

PATHPATH

Driving transformative innovation to save lives

  • Who we are
  • What we do
  • Where we work
  • Resources
About giving »
Donate now »

Fast facts for the media

PATH is the leader in global health innovation. An international nonprofit organization, we save lives and improve health, especially among women and children. We accelerate innovation across five platforms—vaccines, drugs, diagnostics, devices, and system and service innovations—that harness our entrepreneurial insight, scientific and public health expertise, and passion for health equity. By mobilizing partners around the world, we take innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. Together, we deliver measurable results that disrupt the cycle of poor health. See our most recent annual report for particular highlights of our work.

Mission

PATH’s mission is to improve the health of people around the world by advancing technologies, strengthening systems, and encouraging healthy behaviors.

Founded

PATH was originally founded as the Program for the Introduction and Adaptation of Contraceptive Technology (PIACT) in 1977. PIACT transitioned to PATH in 1980. For more information, see the story of the birth of PATH and an overview of our 40 years of health impact.

Headquarters

Mailing address
PO Box 900922
Seattle, WA 98109 USA

Street address
2201 Westlake Avenue, Suite 200
Seattle, WA 98121 USA

Phone: 206.285.3500
Fax: 206.285.6619
Web: www.path.org

Offices

PATH has offices in 40 cities in 20 countries. These countries are Belgium, China, DR Congo, Ethiopia, Ghana, India, Kenya, Malawi, Mozambique, Myanmar, Peru, Senegal, South Africa, Switzerland, Tanzania, Uganda, Ukraine, the United States, Vietnam, and Zambia. Learn more about our global expertise.

Leadership

Steve Davis
President and CEO

Employees

More than 1,600

Funding

PATH is supported by foundations, the US government, other governments, multilateral agencies, corporations, and individuals. Unrestricted funding provided by individual donors is essential to PATH’s work. Unrestricted funding allows us the flexibility to explore opportunities, test new strategies, and invent early prototypes before seeking grant funding, which we typically must use for specific activities.

Our innovation platforms

PATH takes a multidimensional approach to solving health challenges. Our work spans five platforms, which we deploy strategically for greatest impact:

  • Vaccines to give children a healthy start in life.
  • Drugs to treat diseases more effectively and at lower cost.
  • Diagnostics to detect and track diseases.
  • Devices like household water filters and prefilled, nonreusable syringes.
  • And system and service innovations to ensure that all these tools reach the people who need them.

Newsroom

  • Latest news
  • Browse news from PATH
  • Press coverage about PATH
  • Fast facts
  • Experts available

Search the newsroom

Find out more

  • About PATH
  • Our global expertise
  • Frequently asked questions
  • PATH blog
  • Finances
  • Events
RSS Subscribe to the PATH Press Release feed »

Press inquiries

Kate Davidson
Media Relations
206.302.4637
media@path.org

B-roll and photos available upon request.

Share this page

Get updates

Enter your email address for news and updates from PATH. Also, see the topic-specific newsletters we offer.

Connect

  • Events
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Pinterest
  • Google+
  • Instagram
  • Contact

About

  • Our story
  • Leadership
  • Finances
  • Where we work
  • Frequently asked questions
  • Press releases

Explore

  • PATH Blog
  • Multimedia
  • Stories
  • Publications
  • Programs and projects
  • The Vaccine Resource Library
  • Jobs

Donate

  • Donate now
  • Why give?
  • Planned giving
  • Good stewardship
Charity Navigator logo with additional label, ‘12 years at four stars!’
  • Home
  • Current RFPs
  • Privacy policy
  • Copyright policy
  • Terms of use

© 1995–2017, PATH

PATH

PATH Home

About PATH

  • About us
  • Four decades of innovation
  • The birth of PATH
  • Finances
  • FAQs

Leadership

  • Executive leaders
  • Board of directors
  • Program leaders
  • Shared services leaders

How we work

  • Corporate partnerships
  • Global Health Innovation Hub
  • Accountability

Impact

  • Annual reports
  • Stories from the field
  • Awards and honors

Featured

Stylized treatment of the number 40.

Celebrating 40 years of innovation to save lives

Close menu

Our areas of expertise

  • Advocacy and policy
  • Applied behavioral communication
  • Devices
  • Diagnostics
  • Digital health solutions
  • Diarrheal disease and pneumonia
  • Drugs
  • Epidemic and emerging diseases
  • HIV/AIDS
  • Malaria
  • Market dynamics
  • Monitoring and evaluation
  • Neglected tropical diseases
  • Noncommunicable diseases
  • Nutrition
  • Reproductive health
  • Safe birth and newborn care
  • System and service innovations
  • Tuberculosis
  • Vaccines
  • Water, air, sanitation, and hygiene
  • Women's cancers

Featured

Man holding Sayana Press.

Sayana Press injectable contraceptive

Close menu

Global reach

  • Our global expertise
  • Belgium
  • China
  • Democratic Republic of the Congo
  • Ethiopia
  • Ghana
  • India
  • Kenya
  • Malawi
  • Mozambique
  • Myanmar
  • Peru
  • Senegal
  • South Africa
  • Switzerland
  • Tanzania
  • Uganda
  • Ukraine
  • Vietnam
  • Zambia

Featured

Illustration of a globe.

Explore our expertise around the world

Close menu

For our colleagues

  • PATH programs
  • Publications
  • Vaccine Resource Library
  • Online resources

Other resources

  • Jobs
  • Events
  • Newsroom
  • Contact us

Featured

Gloved hands hold a prototype of the new SD BIOLINE Onchocerciasis IgG4 rapid test.

One-stop-shop for vaccine and immunization resources

Close menu

PATH Blog

Newsroom

Jobs

About giving

Contact us